200 related articles for article (PubMed ID: 35569810)
21. Use of MicroRNAs as biomarkers in the early diagnosis of prostate cancer.
Canatan D; Yılmaz O; Sonmez Y; Cim A; Baykara M; Savas M; Coskun HS; Goksu SS; Aktekin MR
Acta Biomed; 2022 Jul; 93(3):e2022089. PubMed ID: 35775783
[TBL] [Abstract][Full Text] [Related]
22. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M
Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077
[TBL] [Abstract][Full Text] [Related]
23. Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population.
Lyu J; Zhao L; Wang F; Ji J; Cao Z; Xu H; Shi X; Zhu Y; Zhang C; Guo F; Yang B; Sun Y
Biomed Res Int; 2019; 2019():9306803. PubMed ID: 31534967
[TBL] [Abstract][Full Text] [Related]
24. A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA.
Brikun I; Nusskern D; Decatus A; Harvey E; Li L; Freije D
Clin Epigenetics; 2018; 10():91. PubMed ID: 29988684
[TBL] [Abstract][Full Text] [Related]
25. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
Dülgeroğlu Y; Eroğlu O
Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
[TBL] [Abstract][Full Text] [Related]
26. The discriminative ability of Prostate Health Index to detect prostate cancer is enhanced in combination with miR-222-3p.
Tölle A; Jung K; Friedersdorff F; Maxeiner A; Lein M; Fendler A; Stephan C
Cancer Biomark; 2021; 30(4):381-393. PubMed ID: 33361585
[TBL] [Abstract][Full Text] [Related]
27. Expression Analysis of miRNAs and Their Potential Role as Biomarkers for Prostate Cancer Detection.
Bergez-Hernández F; Arámbula-Meraz E; Alvarez-Arrazola M; Irigoyen-Arredondo M; Luque-Ortega F; Martínez-Camberos A; Cedano-Prieto D; Contreras-Gutiérrez J; Martínez-Valenzuela C; García-Magallanes N
Am J Mens Health; 2022; 16(5):15579883221120989. PubMed ID: 36082407
[TBL] [Abstract][Full Text] [Related]
28. Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.
Ferro M; Bruzzese D; Perdonà S; Marino A; Mazzarella C; Perruolo G; D'Esposito V; Cosimato V; Buonerba C; Di Lorenzo G; Musi G; De Cobelli O; Chun FK; Terracciano D
PLoS One; 2013; 8(7):e67687. PubMed ID: 23861782
[TBL] [Abstract][Full Text] [Related]
29. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
30. miRNAs as biomarkers in prostate cancer.
Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA
Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165
[TBL] [Abstract][Full Text] [Related]
31. The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report.
Klein EA; Chait A; Hafron JM; Kernen KM; Manickam K; Stephenson AJ; Wagner M; Zhu H; Kestranek A; Zaslavsky B; Stovsky M
Eur Urol; 2017 Dec; 72(6):942-949. PubMed ID: 28396176
[TBL] [Abstract][Full Text] [Related]
32. Unamplified and Real-Time Label-Free miRNA-21 Detection Using Solution-Gated Graphene Transistors in Prostate Cancer Diagnosis.
Deng M; Ren Z; Zhang H; Li Z; Xue C; Wang J; Zhang D; Yang H; Wang X; Li J
Adv Sci (Weinh); 2023 Feb; 10(4):e2205886. PubMed ID: 36480308
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous detection of dual biomarkers using hierarchical MoS
Yan R; Lu N; Han S; Lu Z; Xiao Y; Zhao Z; Zhang M
Biosens Bioelectron; 2022 Feb; 197():113797. PubMed ID: 34818600
[TBL] [Abstract][Full Text] [Related]
34. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
[TBL] [Abstract][Full Text] [Related]
35. Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer.
Byun YJ; Piao XM; Jeong P; Kang HW; Seo SP; Moon SK; Lee JY; Choi YH; Lee HY; Kim WT; Lee SC; Cha EJ; Yun SJ; Kim WJ
Investig Clin Urol; 2021 May; 62(3):340-348. PubMed ID: 33834642
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
37. Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer.
Urabe F; Matsuzaki J; Yamamoto Y; Kimura T; Hara T; Ichikawa M; Takizawa S; Aoki Y; Niida S; Sakamoto H; Kato K; Egawa S; Fujimoto H; Ochiya T
Clin Cancer Res; 2019 May; 25(10):3016-3025. PubMed ID: 30808771
[TBL] [Abstract][Full Text] [Related]
38. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
[TBL] [Abstract][Full Text] [Related]
39. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
Filella X; Foj L
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
[TBL] [Abstract][Full Text] [Related]
40. Hydrogel-based hybridization chain reaction (HCR) for detection of urinary exosomal miRNAs as a diagnostic tool of prostate cancer.
Kim J; Shim JS; Han BH; Kim HJ; Park J; Cho IJ; Kang SG; Kang JY; Bong KW; Choi N
Biosens Bioelectron; 2021 Nov; 192():113504. PubMed ID: 34298498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]